It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
“It is normal protocol at the Mesa Police Department for all death cases (other than obvious natural causes) to be investigated,” Flam said. “All death cases are assigned to a homicide detective for their review as a matter of protocol. Please do not confuse this fact with what is currently being reported that this case is now a homicide investigation.
Oh right a homicide detective would be investigating some other crime, right Phage?...
originally posted by: Phage
a reply to: ElectricUniverse
Oh right a homicide detective would be investigating some other crime, right Phage?...
What crime? Who said there was a crime?
It was not a homicide investigation.
Because as a "homicide investigation" it is being investigated as a possible crime.
“It is normal protocol at the Mesa Police Department for all death cases (other than obvious natural causes) to be investigated,” Flam said. “All death cases are assigned to a homicide detective for their review as a matter of protocol. Please do not confuse this fact with what is currently being reported that this case is now a homicide investigation.
“It is normal protocol at the Mesa Police Department for all death cases (other than obvious natural causes) to be investigated,” Flam said. “All death cases are assigned to a homicide detective for their review as a matter of protocol. Please do not confuse this fact with what is currently being reported that this case is now a homicide investigation
originally posted by: Phage
a reply to: BenjanonFranklin
...
There is nothing stopping doctors from prescribing hydroxychloroquine. ...
Governments are hoarding more than 100 million doses of hydroxychloroquine (HCQ) while victims of COVID-19 are dying from lack of early treatment, which an increasing number of physicians and scientists believe is crucial for saving lives. In many places, particularly in nursing homes, victims of COVID-19 are still unable to access HCQ, states the Association of American Physicians & Surgeons (AAPS).
Pharmaceutical companies donated tens of millions of doses of HCQ to federal and state governments. At least 14.4 million doses of HCQ have been distributed to 14 city governments, the Federal Emergency Management Agency (FEMA) announced.
Yet virtually none of this has gone for early treatment of COVID-19 victims. Many governors and other officials have impeded the availability of HCQ to millions of Americans, including front-line medical personnel in hospitals, COVID-19 patients’ caregivers, and others exposed to the virus.
“Medication is not doing anyone any good sitting in a government warehouse,” observes AAPS executive director Jane Orient, M.D. “This hoarding by government means that most of that medication will probably expire without ever being used.”
...
Many foreign governments support using HCQ early to treat COVID-19, but many tens of thousands of Americans become severely ill, need intensive care, are put on ventilators, and even die without a chance to try HCQ treatment.
The interference by the governor of Nevada with early HCQ treatment has been so egregious that he is being sued by a group of physicians. In most states, officials have issued orders prohibiting or severely restricting access to HCQ by COVID-19 victims. New York refuses to make its enormous stockpile of HCQ available outside a clinical trial. Florida, which has done remarkably well in this crisis, has welcomed, dispersed, and promoted HCQ for its residents.
HCQ is also being used successfully as a prophylaxis in other countries, including India, to protect medical workers, first responders, household contacts, and other persons at risk of exposure. ...
...
This concerns your Executive Order forbidding prophylactic use of chloroquine (CQ) or hydroxychloroquine (HCQ) unless peer-reviewed evidence becomes available.
Attached and posted here (https://(link tracking not allowed)/cqhcqresearch) is a summary of peer-reviewed evidence, indexed in PubMed, concerning the use of CQ and HCQ against coronavirus. We believe that there is clear and convincing evidence of benefit both pre-exposure and post-exposure.
In addition, Michael J. A. Robb, M.D., of Phoenix is compiling all reports as they come in. As of this date, the total number of reported patients treated with HCQ, with or without azithromycin and zinc, is 2,333. Of these, 2,137 or 91.6 percent improved clinically. There were 63 deaths, all but 11 in a single retrospective report from the Veterans Administration where the patients were severely ill. [whereislogic: they basically killed these 52 patients with "horrible care" as elaborate on in this comment; just to make a point against HCQ, intentionally giving it too late and withholding treatment that can dampen the cytokine storm, using treatments to make the problem worse like mechanical ventilation with high pressure, negligence, etc. While giving a different type of care to their 'control group', if you can even call it that (this all relates to what I earlier referred to as the VA study, described as "scientific fraud" by Dr. Raoult).]
Most of the data concerns use of HCQ for treatment, but one study included used the medication as prophylaxis with excellent results. Many nations, including Turkey and India, are protecting medical workers and contacts of infected persons prophylactically. According to worldometers.info, deaths per million persons from COVID-19 as of Apr 27 are 167 in the U.S., 33 in Turkey, and 0.6 in India.
Based on this evidence, we request that you rescind your Executive Orders impeding the use of CQ and HCQ and further order that administrative agencies not impose any requirements on the prescription of CQ, HCQ, azithromycin, or other drugs intended to treat or prevent coronavirus illness that do not apply equally to all approved medications that may be used off-label for any purpose.
President Trump disclosed that he was taking hydroxychloroquine (HCQ) with zinc to protect himself against COVID-19—with the approval of his physicians. Although some in the media may find this startling or concerning, the Association of American Physicians & Surgeons (AAPS) states that thousands and probably millions of people worldwide are doing likewise.
In the U.S., however, patients and physicians who wish to use this long-approved drug, taken safely by 100 million patients over 70 years, are running into barriers set up by the FDA, governors, and state bureaucracies. Among the reports brought to the attention of AAPS is that of a family physician who cannot obtain HCQ for his nursing-home patients.
“It is perfectly legal for physicians to prescribe an approved drug for a newly discovered indication, and very frequently done,” states AAPS. “It is unprecedented for licensure boards to threaten pharmacists who dispense or physicians who prescribe ‘off-label.’” [whereislogic: in my country a general practitioner was shut down from treating his patients with HCQ+Zpack+zinc using this kind of threat, he had little choice other than to stop, otherwise they would have taken away both his license as well as the apothecary's who was in agreement with him and was providing the prescription to his patients. Now there is no one left who prescribes HCQ on time, before patients are admitted to the hospital because it's too late and they were denied admittal to the hospital in the early stages when symptoms were still mild, along with being denied a test and therefore never treated as corona patients nor counted in the national statistics when they die. Murder and involuntary manslaughter are terms that really need to be put on the table here.]
“Basic science research from 15 years ago provides solid reason to expect that HCQ could be effective early in COVID-19, preventing hospitalization and death, and clinical experience from the U.S. and around the globe bears this out,” states AAPS. “It is not likely to work well in seriously sick patients, the only ones who can get it under the FDA’s emergency use authorization (EUA).”
In late April, the FDA issued a new special warning about potential heart problems from use of HCQ in COVID-19—which advises patients with other conditions to continue taking it because benefits exceed the risks.
“The benefit of potentially preventing thousands of hospitalizations and deaths vastly exceeds the risks of HCQ, which has an outstanding safety record,” states AAPS. “And if President Trump’s doctor can prescribe it, why can’t yours?”
The Association of American Physicians and Surgeons (AAPS) has represented physicians of all specialties in all states since 1943. The AAPS motto is omnia pro aegroto, meaning everything for the patient.
originally posted by: IAMTAT
Out of the blue...in a Press conference, today...and while answering a question...President Trump admitted he has been taking Hydroxychloroquine as a preventative for a week or so.
He said he asked the WH doctor about it...and was told he could try it if he wanted to.
Interesting development.
PLEASE READ:
THIS IS NOT THE MUD PIT
edit on Tue May 19 2020 by DontTreadOnMe because: IMPORTANT: New (old) Standards Are Being Enforced (again) For New Threads
Source: www.cbsnews.com...
President Trump will soon be ending his course of hydroxychloroquine, he told reporters Wednesday.
"I think the regimen finishes in a day or two — yeah, I think it's two days, two days," he said during a meeting with Arkansas Governor Asa Hutchinson and Kansas Governor Laura Kelly.
originally posted by: whereislogic
...
I'll have another go at the rather crucial link in my previous comment that isn't working (regarding the accumulating evidence of HCQ's effectiveness):
cqhcqresearch
24 March 2020
Pagliano P, Piazza O, De Caro F, Ascione T, Filippelli A. Is Hydroxychloroquine a possible post-exposure prophylaxis drug to limit the transmission to health care workers exposed to COVID19? Clin Infect Dis. 2020 Mar 24. www.ncbi.nlm.nih.gov...
PMID: 32211764 DOI: 10.1093/cid/ciaa320
Chloroquine and Hydroxychloroquine are able to inhibit replication at early stages of viral infection. No similar effect on early phases of Coronavirus infection has been reported for other drugs proposed for SARS-CoV-2 treatment, which are able to interfere only after cell infection.
We believe that hydroxychloroquine can be effective in preventing respiratory tract invasion in HCW and that hydroxychloroquine administration as prophylactic agent could be particularly useful for HCW attending to high risk procedures on respiratory tract in COVID-19 patients.
Hydroxychloroquine effectiveness profile, its ability to inhibit lung viral replication for a 10-day period after only a 5- day cycle of therapy, and the large amounts of knowledge in term of safety deriving from its use for malaria prophylaxis and rheumatologic diseases permit to recommend its pre-exposure or post-exposure use for those performing procedures at high risk of viral diffusion in patients with COVID-19 pneumonia.
originally posted by: mugger
I was listening to Glen Beck a few days back.
Apparently, Fredo Cuomo and his wife took Quinine when he had it. Published on her blog.
Why would he do that? I guess the original tree bark works but the man-made doesn't?
The analysis included data from 671 hospitals across six continents, which pooled together resulted in 96,032 patients who had tested positive for COVID-19 and were hospitalized between Dec. 2019 and April 2020. Of this population,1,868 patients received chloroquine, 3,783 received chloroquine with a macrolide, 3,016 received hydroxychloroquine, and 6,221 received hydroxychloroquine with a macrolide. The other 81,144 patients served as a control group. Patients who had received remdesivir were excluded, as were those who were given the medications 48 hours after being placed on a ventilator. In total, 10,698 patients died while in the hospital.
The researchers said that after considering multiple confounding factors when compared with mortality in the control group, hydroxychloroquine, hydroxychloroquine with macrolide, chloroquine, and chloroquine with a macrolide were “independently associated with an increased risk of de-novo ventricular arrhythmia during hospitalization.”
Further, the researchers concluded that they were unable to “confirm a benefit of hydroxychloroquine or chloroquine when used alone or with a macrolide, on in-hospital outcomes for COVID-19.”
originally posted by: whereislogic
a reply to: Grimpachi
Yay, another marketing sales-pitch report downplaying HCQ's well-established and proven highly effectiveness to set up the useless highly toxic snake-oil Remdesivir as the one to go with (exactly as I predicted in another thread, but to actually use the same source as already discussed in the Raoult video concerning Remdesivir, that's ballsy).
Way to copy-paste the MSM's and Big Pharma's talking points...so useful on a forum that is supposed to be "AboveTopSecret" and about denying the ignorance promoted by the MSM and the system of things.
The New England Journal of Medicine (your source of publication) has lost all credibility. Anyone who thinks they've got something worth your while to publish, check out the 2nd video of Dr. Raoult for a response to the NEJM and their behaviour in terms of scientific integrity and honesty vs a conflict of interest with Big Pharma pulling the strings.
From the piece you quoted yourself, as if you don't even get how such a negative marketing/sales-pitch report works:
Hydroxychloroquine-treated patients were more severely ill at baseline than those who did not receive hydroxychloroquine...
Basically the same trick as the VA study. It's written into the protocols to give it when it's too late, so you can then say: 'see, it doesn't work'. Add a bit of bad health care and neglect to it; no attempt to treat the cytokine storm (... details available here, see under "Dampening the Storm"), while you perhaps do treat it in your group that isn't getting HCQ, and don't continue with HCQ on the HCQ group if it takes a bit longer than what the protocol says, stop their antibiotica (azithromycin) regime when they still need it or never add it in the first place, don't give them Vitamin C and zinc at least, no HFNC, CPAP or BiPAP, but straight to the closed system intubation with badly managed pressures, etc.:
And you're good to go to fudge the numbers and give a false impression for something that has already been proven to be highly effective in early stages of the disease (before the cytokine storm) and prophylactically. No marketing/sales-pitch reports presented under the marketinglabel "science" will ever change that reality. [addition May 23: that counts for future reports, like the one Grimpachi just shared in this thread; a hint that when I made this comment I was already expecting the type of marketing/sales-pitch report that was just used in this thread. These type of reports will continue to come out for a while until enough doubt has been cast in the eyes of those writing the toxic Remdesivir into protocols or having influence thereon, or wanting people to take their upcoming useless vaccin; which I would not be surprised will be so toxic that it causes exactly the type of harm they are now ascribing to HCQ]
Once more for those who still don't get it, pay specific attention to what's mentioned after 1:30 (note the source New England Journal of Medicine mentioned at 2:19):
The NEJM is not a scientific source, it's a marketing source (company) connected to Big Pharma. They, and those publishing under their name, are not functioning as scientists (or science news reporters) but marketeers*. You can't take them seriously on any subject that might affect Big Pharma's bottem line. *: and because they are posing as serious honest scientists (or science news reporters; they work together in this manner), it makes them charletans, con-artists, frauds, deceivers, careerjunkies (all appropiate descriptions in this case)
"Also, they will greedily exploit you with counterfeit words. But their judgment, decided long ago, is not moving slowly, and their destruction is not sleeping." (2 Peter 2:3)